Articular Engineering, LLC is an Illinois based biotech company committed to the advancement of current treatment options for articular cartilage and intervertebral disc disorders. In 1999 Articular Engineering opened with cell-based and tissue modifying core technologies targeting articular cartilage and intervertebral disc repair and regeneration. These technologies currently in development have resulted in numerous patents. Building on core strengths and knowledge of the field, in 2002 Articular Engineering began providing custom orthopaedic tissues and cultures to researchers. Today Articular Engineering provides joint and spine tissues and cultures to the pharmaceutical and biotech industries worldwide.

Customizable Products

Articular Engineering understands the need for custom tissues and cultures, ready to use and able to meet very specific protocols. For this reason Articular Engineering specializes in customizable cell cultures and tissue products. All tissues and cells are freshly isolated and phenotypically stable. Tissues include intervertebral disc, cartilage, bone, synovial tissue and synovial fluid. Most other tissues are available upon request. Tissues can be shipped whole, fresh or frozen, cultured as explants or prepared with additives for histology, RNA, DNA or protein extraction. Freshly isolated cells can be plated in monolayer or alginate bead culture or used for tissue engineering. Plate formats, seeding density, media, and culture additives can be prepared to meet most specifications.

Human Ethics Policy

Articular Engineering Human Ethics Policy.


Available upon request. Contact us.

Our Clients

Abbvie Bioresearch Center Fiocruz Queen Mary University of London
ACell Five Prime Therapeutics RN Bio Research
Active Motiff Fordham University Roche Pala Alto, LLC
Adv Tech & Regen Med., LLC Galapagos NV Rush University
Aesculap Implant Systems Gentaur Europe BVBA Sankyo Co., LTD.
Amedica Genzyme Sanofi Pasteur
Amgen Genzyme Biosurgery The Scripps Research Institute
AnGes MG, Inc Georgia Institute of Technology Shigematsu Co.
Arresto Biosciences The Hartwell Foundation Stoneybrook University
Arsenal Medical, Inc Ibis Biosciences Stryker Orthopaedics
Atreca Inception Sciences Canada, Inc. Taurus Scientific Inc
Aurigene Discovery Technologies Limited Innovative Elements Tetec
Biomet Ironwood Phamaceuticals Thomas Jefferson University
BioMimetic Therapeutics, Inc. IsoTis OrthoBiologics Tissue Solutions
Bioworks J&J Consumer& Personal Products TNO
Boehinger Ingelheim J&J PRD LLC Trevena, Inc
Buck Institute Janssen Research & Development, LLC Tufts University
CA Institute of Tech Johns Hopkins University University of California San Diego
Calosyn Phara MCPHS University University of Illinois Chicago
Centocor MD Biosciences University of Arkansas UAMS
Children’s Hospital of Philadelphia MedinCell University of Auckland
Childrens Health Medtonic University of Connecticut Health Center
CombinatoRx Medtronic Spine, LLC University of Delaware
Cosmo Bio Co. Merck Serono University of Hawaii
Daiichi Sankyo Momenta Pharmaceuticals, Inc University of Heidelberg
Da Vinci Biologics, LLC Nippon University of Manchester
Dr. Reddy's Laboratory, Ltd. Northeast Ohio Medical University University of Miami
Duke University Novo Nordisk University of Rochester
DuPuy NUI Galway University of Oxford
Albert Einstein College of Medicine Nutramax Labloratories, Inc. Wako Pure Chemicals
Eli Lilly New York Institiute of Technology Wyeth Research
Erasmus MC, University Medical Center Omeros Zimer Orthobiologics
Ethicon, Inc. Ortho-Mc Neil Pharmaceutical Corp.  

Product Claims and Replacement Items

  • Regarding tissues and cells, Articular Engineering does not guarentee any specific experimental outcome, expression of protein, gene,  or similar. 
  • Claims for refunds or replacements must be made within 1 month of receipt of goods and documented with laboratory records, pictures and explaination.  Articular Engineering will NOT COVER SHIPPNG costs on replacement items.
  • In order to recieve replacement cells, researcher must use Articular Engineering Growth media. Cells must be cultured as directed for a minimum of 1 week.